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Rats were infused intravenously with a bolus of mevalonolactone or cholesterol-rich c ylomicron and 
microsomes prepared from the livers at times up to 2 h after the infusion. Acyl-CoA cholesterol 
acyltransferase (ACAT) activity was measured inthe microsomes under conditions that define the activity 
state of the enzyme which recent evidence suggests may depend on the degree of phosphorylation of the 
enzyme. ACAT activity was increased by both treatments. Some of the observed increase could be 
attributed to an increase in the supply of substrate cholesterol to the enzyme. The remaining change in 
activity was consistent with a change in the activity state of ACAT occurring in vivo in response to the 
influx of cholesterol to the enzyme 
Acyl-CoA:cholesterol acyltransferase 
1. INTRODUCTION 
Three enzymes have attracted attention in recent 
years in studies on the regulation of hepatic 
cholesterol metabolism. Most studies have concen- 
trated on 3-hydroxy3-methylglutaryl-coenzyme 
A reductase (HMG-CoA reductase) as the rate- 
limiting step of cholesterol biosynthesis [ 11. 
Cholesterol-7cu-hydroxylase has been examined as 
the regulatory enzyme in the conversion of 
cholesterol into bile acids [2] and more recently the 
role of acyl-CoA-cholesterol acyltransferase 
(ACAT) in regulating cholesterol esterification has 
been studied [3]. In vitro experiments for all 3 en- 
zymes have been reported which lead to the view 
that they may all be regulated by a short-term 
phosphorylation-dephosphorylation mechanism 
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which results in inhibition of HMG-CoA reduc- 
tase by phosphorylation and activation of the 
other two enzymes [1,4-lo]. It has been suggested 
that such a mechanism may operate in vivo to 
coordinately control hepatic cholesterol metabol- 
ism [6,7]. However, only in the case of HMG- 
CoA reductase is there any evidence to suggest hat 
changes in the activity state of the enzyme in 
parallel with its degree of phosphorylation may oc- 
cur in vivo. Infusion of mevalonolactone into rats 
intragastrically decreases the activity of hepatic 
HMG-CoA reductase after 20 min by enzyme 
phosphorylation without altering the amount of 
enzyme present [1,&I]. Short-term (60 min) chol- 
esterol feeding has a comparable effect on the en- 
zyme [1,9]: Treatment of isolated rat hepatocytes 
with glucagon has also been shown to alter the ac- 
tivity state of the reductase [lo]. 
We have reported that the apparent activity of 
ACAT in vitro in rat liver and intestine could be 
modulated both by altering the supply of substrate 
cholesterol and by a mechanism which was shown 
to be dependent on ATP/MgClz and 100000 x g 
supernatant protein in the presence of NaF [6]. 
The activity of ACAT in freshly prepared 
Published by Elsevier Science Publishers B. V. 
OO145793/83/$3.C4l 0 1983 Federation of European Biochemical Societies 29 
Volume 159, number 1,2 FEBS LETTERS August 1983 
microsomes was found to be very close to its 
minimum level. We here report experiments which 
were designed to investigate whether the activity 
state of rat liver microsomes towards cholesterol 
esterification could be altered in vivo by in- 
travenous infusion of mevalonolactone and also of 
cholesterol-rich chylomicrons over short periods of 
time of up to 2 h. The rate of cholesteryl ester for- 
mation in liver microsomal fractions from ex- 
perimental and control animals, which were 
treated in a variety of ways to define the activity 
state [6], was measured using [ l-‘4C]oleoyl-CoA 
as substrate. The results show that an increase in 
the rate of cholesteryl ester formation could be 
achieved by both in viva treatments and that this 
increase could be ascribed partly to a greater supp- 
ly of substrate cholesterol due to the infusions and 
partly to a change in the activity state of ACAT as 
assessed in vitro. 
2. MATERIAL AND METHODS 
Female Sprague-Dawley rats (CD*(SD)BR), 
Charles River Breeding Labs. (Wilmington MA) 
weighing about 150 g were fitted with femoral vein 
catheters and placed in restraining cages. A solu- 
tion untying 0.9~~ (w/v) NaCI, 4.5 mM KC1 
and 20% (w/v) glucose was infused into the 
femoral vein overnight at a rate of 1 ml/min. A 
bolus of mevalonolactone (200 mg) or cholesterol- 
rich chylomicrons (10.5 mg cholesterol) was ad- 
ministered to each group at the start of the experi- 
ment, and the animals were then left for the re- 
quired time (up to 2 h). Control animals received 
a bolus of 0.9% saline. At the end of the ex- 
perimental period the rats were anaesthetised with 
diethyl ester and the livers rapidly perfused with 
cold 154 mM KC1 and removed. The microsomal 
fractions from the control and experimental 
animals and the 100000 x g supernatant fraction 
from control animals were prepared as in [6]. The 
apparent ACAT activity in the various microsomal 
preparations was determined as in [6]. 
Donor rats for the preparation of cholesterol- 
rich chylo~crons were fitted with an in- 
traduodenal catheter and the intestinal ymph duct 
was cannulated [l 11. A medium consisting of the 
NaCl-KCl-glucose solution (described above) 
also containing 10 mM sodium taurocholate, 2 
mM cholesterol and 3% (w/v) fatty acid-free 
30 
bovine serum albumin was infused intraduodenally 
(2.4 ml/h). The cholesterol was added to the other 
components of the medium in solution in hot 
ethanol and the mixture was then sonicated for 5 
min. The cholesterol-rich chylomicrons were pre- 
pared from the intestinal ymph by ultracentrifuga- 
tion and dialysis as in [ 121. 
3. RESULTS AND DISCUSSION 
Rat liver microsomal ACAT activity is known to 
be increased by intragastric administration of 
mevalonolactone [13,14] and similar effects can 
also be observed in cultured hepatocytes [15]. In 
the experiments described in table 1 rats were in- 
fused intravenously with a bolus of mevalonolac- 
tone and the liver microsomal fraction was isolated 
after various periods of time. The ACAT activity 
of the untreated microsomes (column 1) increased 
significantly with time after mevalonolactone ad- 
ministration. Pr~ncubation of these microsomes 
with the pooled 100000 x g supernatant fraction 
obtained from the livers of control animals (under 
conditions which have been shown to reverse the 
ATP-dependent activation in vitro [6]) nearly 
abolished this observed rise in basal ACAT activity 
(column 2). The in~bition was virtually complete 
at 20 min, but the activity of the microsomes re- 
mained somewhat higher at 60 min. This residual 
activity difference may indicate an increase in the 
supply of the substrate cholesterol to the 
acyltransferase from stero1 newly-synthesized from 
the mevalonate during the 6Omin interval. 
All the microsomal fractions could be activated 
to the same level by preincubation with ATP, 
MgClz, NaF and 100000 x g supernatant. This 
shows that, whilst the activity of the untreated 
microsomes differed with time (column 1), the 
same maximum activity could be obtained with 
each microsomal group (column 3) after this 
treatment. 
Preincubations were also carried out in the 
presence of cholesterol-rich liposomes [6] to 
demonstrate further that substrate supply also was 
important in regulating the amounts of cholesteryl 
ester formed by the different microsomal prepara- 
tions. The data in columns 4 and 5 of table 1 show 
that although the relative increase varied (com- 
pared to column l), identical maximal levels of ac- 
tivity were obtained for all 3 groups of animals. 
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Table 1 
Effect of intravenously administered mevalonolactone on rat liver microsomal ACAT activity 
(pmol cholesteryl oleate formed.min-‘.mg protein-‘) 
1 2 3 4 5 
0 min 44.8 f 6 54.0 f 5 212.4 III 15 102.0 f 14 524.0 f 62 
20 min 79.3 f S8 50.8 f 5 221.9 f 49 103.0 f 8 407.0 f 65 
60 min 132.5 f lO* 73.2 + 4a 224.0 f 34 132.0 f 9 504.0 f 22 
Results are expressed as the mean f 1 SEM for 4 animals in each experimental group. Differences 
between groups were tested for significance using the unpaired Student’s t-test 
* Value is significantly different at the p c 0.05 level as compared with the control group 
(O-time group) 
Rats fitted with femoral vein catheters were injected with a bolus of 200 mg mevalonolactone in a 
volume of 2 ml and groups were killed immediately or 20 min and 60 min later: Column: (1) ACAT 
activity of untreated microsomes in these 3 groups; (2) activity measured after 30 min preincubation 
of microsomes with 100008 x g supernatant and 2 mM MgCL; (3) activity after incubation of 
microsomes for 90 min with 100000 x g supernatant, 4 mM ATP, 4 mM MgCh and 40 mM NaF; 
(4) activity after a 90 min preincubation of the microsomes with cholesterol-rich liposomes; 
(5) microsomes incubated as in column 3 with the addition of cholesterol-rich liposomes. 
An identical group of experiments was perform- 
ed in which the rats were infused with cholesterol- 
rich chylomicrons for periods of 1 and 2 h (table 
2). Table 2 shows that no significant differences 
were observed over the O-time animals with the 1 h 
infusion. After 2 h, however, a significant increase 
was observed in the activity of the microsomes, 
and this could be partially prevented by preincuba- 
tion with the 100000 x g supernatant (column 2). 
The most direct interpretation of these results is 
that the infusion of cholesterol-rich chylomicrons 
and mevalonolactone caused an increase in the 
supply of substrate-cholesterol to the endoplasmic 
reticulum of the liver and that this resulted in the 
increases in the amounts of cholesteryl ester form- 
ed. This is particularly apparent 60 min after the 
administration of mevalonolactone and 2 h, after 
the chylomicron infusion, since the relative in- 
crease in ACAT activity through enrichment of the 
cholesterol substrate supply from liposomes (col- 
umns 4 in table 1,2) was much less pronounced in 
these groups (l.O-1.3-fold) that in the O-time 
groups (2.4-fold). 
However, incubation of the microsomes under 
conditions that inhibit ACAT activity through 
dephosphorylation [6] completely reversed the ac- 
Table 2 
Effect of intravenously administered cholesterol-rich chylomicrons on rat liver microsomal ACAT 
activity (pm01 cholesteryl oleate formed .min-’ . mg protein- ‘) 
1 2 3 4 5 
Oh 20.3 f 2.4 25.1 f 1.3 74.3 f 4.5 52.3 f 3.1 172.7 f 9 
lh 23.5 f 2.3 25.5 f 3.0 64.6 f 7.1 52.4 f 5.3 174.3 f 
2h 
15.9 
57.3 f 5.4a 38.2 f 5.2* 116.0 f 19 76.4 f 8a 210.8 f 32 
*See table 1 
Rats were injected with a bolus of cholesterol-rich chylomicrons containing 10.3 mg cholesterol in 
2 ml. The microsomal treatments are as described in table 1 
31 
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tivation observed in the 20-min mevalonolactone 
group (column 2, table 1) and largely reversed the 
effect of both mevalonolactone and chylomicrons 
at 60 min and 2 h, respectively. A similar inactiva- 
tion was recently observed in hepatic microsomes 
after in vitro activation through ATP-dependent 
phosphorylation [6]. It seems likely, therefore, 
that the majority of the activation after both short- 
term treatments is due to a similar process occurr- 
ing in vivo. Notably, this ACAT activation 
through apparent phosphorylation follows a time 
course similar to the inactivation of HMG-CoA 
reductase by its kinase [1,8]. 
It should also be noted that the activities 
measured after full activation through both in- 
creased substrate supply and phosphorylation (col- 
umns 5, table 1, 2) were not significantly different 
at the different time intervals in both treatment 
groups. The data, therefore, are consistent with a 
short term, in vivo regulation of hepatic ACAT ac- 
tivity both through phosphorylation and substrate 
supply, rather than a change in enzyme synthesis, 
and support our suggestion [6] of a coordinate 
control with HMG-CoA reductase under the con- 
ditions studied [ 1,8,9]. 
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